The EGSA Polyclonal Antibody (PAC035038) is an essential tool for researchers studying EGSA, a key protein involved in immuno-oncology. This antibody, generated in rabbits, exhibits high reactivity towards EGSA in human samples and is validated for Western blot applications. By specifically binding to the EGSA protein, this antibody enables accurate detection and analysis in various cell types, making it an ideal choice for investigations in immunology and cancer research.EGSA, also known as a potential immune checkpoint target, plays a crucial role in immune response regulation by modulating immune system activity and inhibiting anti-tumor responses.
Its significance in cancer immunotherapy research highlights the importance of understanding its function in order to develop targeted therapies for cancer treatment. With its ability to assist in the analysis of EGSA expression and activity, the EGSA Polyclonal Antibody is an invaluable tool for advancing research in immuno-oncology and therapeutic development.
Antibody Name:
egsA Antibody (PACO35038)
Antibody SKU:
PACO35038
Size:
50ug
Host Species:
Rabbit
Tested Applications:
ELISA
Recommended Dilutions:
Species Reactivity:
Geobacillus stearothermophilus
Immunogen:
Recombinant Geobacillus stearothermophilus Glycerol-1-phosphate dehydrogenase [NAD(P) + ] protein (1-404AA)
Catalyzes the NAD(P)H-dependent reduction of dihydroxyacetonephosphate (DHAP or glycerone phosphate) to glycerol 1-phosphate (G1P). The G1P thus generated is probably used for the synthesis of phosphoglycerolipids in Gram-positive bacterial species.
Catalyzes the NAD(P)H-dependent reduction of dihydroxyacetonephosphate (DHAP or glycerone phosphate) to glycerol 1-phosphate (G1P). The G1P thus generated is probably used for the synthesis of phosphoglycerolipids in Gram-positive bacterial species.
